- $322.26m
- $280.50m
- $57.72m
- 49
- 21
- 90
- 53
Annual income statement for Arteris, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 31.8 | 37.9 | 50.4 | 53.7 | 57.7 |
| Cost of Revenue | |||||
| Gross Profit | 30.3 | 34.1 | 46.1 | 48.6 | 51.8 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 34 | 59.6 | 79.2 | 88.8 | 89.3 |
| Operating Profit | -2.18 | -21.8 | -28.9 | -35.1 | -31.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.23 | -22.3 | -27.8 | -35.2 | -31.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.23 | -23.4 | -27.4 | -36.9 | -33.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.26 | -23.4 | -27.4 | -36.9 | -33.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.26 | -23.4 | -27.4 | -36.9 | -33.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.08 | -1.06 | -0.841 | -1.03 | -0.864 |